Arranon
Arranon Overview
Arranon (generic: nelarabine) is a prescription medication used to treat relapsed or refractory T-cell acute lymphoblastic leukemia (ALL) and T-cell lymphoblastic lymphoma (rare cancer of the immune system's own T-cells). Arranon belongs to a group of drugs called antineoplastic agents. These medications work by interfering with the growth and spread of cancer cells in the body.
Arranon comes in an injectable form to be given intravenously (into a vein) in a clinic or hospital. In adults, it is usually given once a day on the first, third, and fifth days of the dosing cycle. In children, Arranon is usually given once daily for 5 days, repeating every 21 days.
Common side effects of Arranon include headache, sleepiness, blurry eyesight, and decreased blood counts.
